Wound Botulism Questionnaire SECTION 1: DEMOGRAPHIC INFORMATION

Similar documents
An infected insect bite? Dr Estée Török Honorary Consultant in Infectious Diseases & Microbiology Addenbrooke s Hospital, Cambridge

BOTULISM INVESTIGATION FORM

Public Health Update

SPEEDBALLS INJECTING HEROIN & CRACK (OR COCAINE)

This survey should take around 15 minutes to fill in. Please be as honest as you can.

Expanded Case Summary 4: Botulism.

London Pathway Evaluation

Somerset Phoenix Project: Self-request for support

Botulism Poisoning Patient Scenario

Fax completed form to: (204) Further inquiries: your CD Coordinator

APPLICATION FOR PODIATRY ASSESSMENT

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada

Tips For A Safer Injection

Patient Details. Other: Chemotherapy Long term steroids Organ transplant Splenectomy HIV CD4 count if known:

Operational Guideline

BHIVA national clinical audit 2018: monitoring of adults with HIV aged 50 or over

Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?

Westminster IAPT Primary Care Psychology Service. Opt-In Questionnaire

BRAIN STEM CASE HISTORIES CASE HISTORY VII

BC Enhanced Hepatitis Strain Surveillance Project Hepatitis B. Acute HBV Questionnaire

If you have any difficulties in filling out the forms, please contact our team administrator on

FIDGET CUBE / SPINNER HAVE A BREAK WATER

London Pathway Evaluation

MEDICAL QUESTIONNAIRE (male)

Standard Gastrointestinal Disease Questionnaire

Diabetes services in Leicester - Have your say

Ceritinib (Zykadia )

For the Patient: Ponatinib Other names: ICLUSIG

Dubious Botulinum Neurotoxin: A Brief Introduction 刘英琪生物科学

Wound Botulism. Ai-Ling Lin, DO Internal Medicine PGY4 November 1st, 2016 CDC

Welcome to Wonersh Surgery. In order for us to provide you with the best medical care please complete this Questionnaire and pass to Reception.

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX

PACKAGE LEAFLET: INFORMATION FOR THE USER

For the Patient: Fludarabine injection Other names: FLUDARA

Substance misuse among young people The data for

Yellow PracticeNewPatient Information Card

SCOTTISH STROKE CARE AUDIT DATA COLLECTION QUICK NOTES

This guide describes some of the important facts about Neurobloc that you need to be aware of, however, it does not replace the advice given to you

Worcestershire Dementia Strategy

Detection of Hepatitis B and C in Primary Care

Stop Smoking Service Client Record Form 1

GOING IN THE INJECTING THE

Date of Visit / / Date of Birth / / Age

Cranial Nerves Exam. 1. To learn how to examine the functions of the 12 pairs of cranial nerves.

(e.g. permanent, asylum seeker)

TABLE OF CONTENTS 2.0 GOAL... 2

Patient Name: First MI Last Preferred Name. DOB: Sex: MALE FEMALE SSN: Address: City: State: Zip Code:

Cancer of the oropharynx

Additional details about you What is your ethnic group? Name of next of kin \ Emergency contact

Rules of Engagement HPI. HPI (cont.)

Initial History Form

Patient Care Planning Group April 3, 2014

ACUPUNCTURE SPECIFIC INTAKE FORM

For the Patient: Bendamustine Other names: TREANDA

SANTA MONICA BREAST CENTER INTAKE FORM

Name: Date of Birth: Age:

Amarillo Surgical Group Doctor: Date:

SIGNS AND SYMPTOMS OF SUBSTANCE USE

Basic Epi: Differential Diagnosis of Foodborne Illnesses. One Foodborne Investigation Strategy. Second Strategy: Differential Diagnosis

Somerset Phoenix Project: Parent/Carer request for support

PATIENT REGISTRATION

International IBD Genetics Consortium

Chronic Hepatitis C The Patient s Perspective

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Who this handbook is for?

Aims. To gain a greater awareness and understanding of risks associated with different substances and routes of administration

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)

For the Patient: LUAVPEM

Margie Petersen Breast Center

Drug information. Belimumab BELIMUMAB. is used to treat lupus (SLE) Helpline

For the Patient: Trastuzumab emtansine Other names: KADCYLA

Submission to Bedfordshire Consultation on IVF Services September We are supported by the following organisations:

PAIN/MEDICAL QUESTIONNAIRE

Needle and syringe distribution

THE KEATS GROUP PRACTICE REGISTRATION FORM PLEASE COMPLETE IN BLOCK CAPITALS PERSONAL BACKGROUND INFORMATION

Produced by La Direction des communications du ministère de la Santé et des Services sociaux

Hull and East Riding CAMHS Professional Referral Form

CECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425)

5.1 Alex.

Atrovent Metered Aerosol (CFC Free)

Gabapentin Questionnaire

1.0 Presenting complaint: Onset 1.1 When it started? 1.2 How did it start? Progress 1.3 Has the problem increased /decreased so far?

Amphetamine 2. speed : whizz : base : amphet : sulphate WHAT & WHY?

Ramsay Hunt syndrome. and facial palsy

Milton Keynes Draft Dementia Strategy - A Consultation

Laser Vein Center Thomas Wright MD Page 1 of 4

MEDICAL QUESTIONNAIRE (female)

Proposals for new health services for coeliac patients in Somerset

Total Thyroidectomy. Post-Surgery Instructions for: WHAT YOU SHOULD KNOW:

Nivolumab. Nivolumab

Patient History (Please Print)

Analysis of Greater Glasgow & Clyde IEP Data John Campbell

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: Eribulin Other names: HALAVEN

Corinna Mosher, M.D. A Medical Corporation 415 E. Rolling Oaks Drive Suite #280 Thousand Oaks, CA (805) Fax (805)

Alectinib (Alecensa ) Alectinib (Alecensa )

CONSULTATION ADMITTANCE FORM

Patient Name: Date: Address: Primary Care Physician: Online Website On TV In print On the radio

SOC SEC #: - - Date of Birth: - - Age: yrs. State: Zip Code: Employer:

Name: Date: Sex: Male Female Date of Birth(DD/MM/YY): Address: City: Postal Code: Phone #: (Home) (Work) (Cell) (Other) Address:

Transcription:

Wound Botulism Questionnaire For cases of wound botulism among people who inject drugs please complete this questionnaire. If food botulism is suspected please complete the adult food botulism questionnaire which can be found on the PHE website. There is also a separate questionnaire for cases of infant botulism which can be found on the PHE website. Please return completed questionnaire by email (encrypted), post or fax to: Katelyn Cullen IDU Team Centre for Infectious Disease Surveillance and Control Public Health England 61 Colindale Avenue Fax: 020 8200 7868 London Tel: 020 8327 7547 NW9 5EQ Email: Katelyn.Cullen@phe.gov.uk SECTION 1: DEMOGRAPHIC INFORMATION Q.1 Patient name For CIDSC use only: Number: Week of notification: Source of reporting: For queries regarding the wound botulism Vivian.Hope@phe.gov.uk Tel: 020 8327 7930 questionnaire please contact: Fortune.Ncube@phe.gov.uk Tel: 020 8327 6423 Kathie.Grant@phe.gov.uk Tel: 020 8327 7117 Surname First name Q.2 Sex Male Female Q.3 Q.4 Q.5 Date of birth Age (years) Address / /. dd/mm/yyyy Q.6 Ethnic group White British White Irish White other Other Not known Black-Caribbean Black-African Black-Other Pakistani Bangladeshi Indian Chinese Asian other Q.7 Occupation Q.8 Has the patient been involved in any activities that might expose wounds to soil e.g. gardening, carpentry, etc? Q.9 Has the patient travelled away from home or overseas in the last month?.. Specify place:.. Specify dates: From. To. 2006.1.4 Dec 2013 (PWID wound botulism & PHE logo)

SECTION 2: CLINICAL DETAILS Q.10 Hospital Name Q.11 Clinician in charge Name Tel no. Q.12 GP Name Address Q.13 Preliminary History: Tel no. Day Month Year A. Onset date of symptoms B. Date first seen by doctor C. Was patient hospitalised? If yes: date hospitalised D. Has the patient been admitted to intensive care? If yes: date admitted E. Has the patient been placed on a ventilator? If yes: date intubated: Q.14 Was the patient on any of the following medications in the month prior to onset? a. Phenothiazine b. Aminoglycoside c. Anticholinergic Yes Yes Yes No No No Q.15 Clinical History: Briefly describe history and general symptom progression: 2

SECTION 2: CLINICAL DETAILS (continued) Q.16 Specific symptom history: Abdominal pain Nausea Vomiting Diarrhoea Constipation Blurred vision Diplopia Dizziness Slurred speech Thick tongue Change in sound of voice Hoarseness Dry mouth Difficulty swallowing Shortness of breath Subjective weakness Fatigue Paraesthesia If yes, please describe site of paraesthesia: Does the patient have a wound, boil or abscesses, no matter how trivial? If yes, please describe site and nature:.... Q.17 Vital signs on admission: Temperature (C).. Blood Pressure Heart Rate Respiratory Rate /......

SECTION 2: CLINICAL DETAILS (continued) Q.18 Physical Examination Findings: Altered mental state Extraocular palsy Ptosis Pupils Dilated Pupils constricted Pupils fixed Pupils reactive Facial paralysis Palatal weakness Impaired gag reflex Sensory deficit(s) If yes, please describe deficit:. Q.19 Deep tendon reflexes: Abnormal deep tendon reflexes Biceps/Triceps Brachial Patellar Ankle BRISK RMAL REDUCED ABSENT BRISK RMAL REDUCED ABSENT BRISK RMAL REDUCED ABSENT BRISK RMAL REDUCED ABSENT BRISK RMAL REDUCED ABSENT Q.20 Please indicate if weakness or paralysis was noted in the patient: a. Upper extremities If yes: Distal weakness/paralysis Proximal weakness/paralysis b. Lower extremities If yes: Distal weakness/paralysis Proximal weakness/paralysis If yes to any of the above please describe weakness/paralysis: i. Ascending (beginning in the lower extremities, moving to upper extremities and then cranial nerves) ii. Descending (beginning with cranial nerves, moving to upper then lower extremities) 4

SECTION 2: CLINICAL DETAILS (continued) Q.21 Laboratory Results: a. Was a lumbar puncture done? If yes: i. Date done: ii. RBC iii. WBC iv. Protein v. Glucose b. Was a tensilon test (Edrophonium chloride) done? / /. dd/mm/yyyy............ If yes: i. Date done: ii. Results: / /.dd/mm/yyyy...... c. Was electromyography (EMG) done? If yes: i. Date done: ii. Muscle group iii. Nerve conduction results iv. Was rapid repetitive stimulation conducted? If yes: Hertz: d. Was brain imaging done? If yes: Was an MRI done? Result: Was a CT done? If yes: i. Date done: ii. Findings: If yes: i. Date done: ii. Findings: / /.dd/mm/yyyy...... / /.dd/mm/yyyy / /.dd/mm/yyyy 5

SECTION 2: CLINICAL DETAILS (continued) Q.22 Treatment Was surgical debridement performed? Was the patient treated with antimicrobial agents? Yes No If yes, please state which agents were used Q.23 What samples have been sent to test for botulinum toxin? Serum Pus Q.24 Botulinum antitoxin: Wound tissue Other (please state).. Was the patient given Antitoxin? If yes, how many doses were given?: Dates given? Q.25 Differential Diagnosis by Clinician:.. Q.26 Patient outcome/status: Still ventilated Still in hospital Discharged Died Date of outcome.. Q.27 Is the patient a known drug user? 6

SECTION 3: QUESTIONS FOR DRUG USERS Q.28 In the last month have you injected any of the following drugs?: Q.29 For how many years/months have you been using these drugs? Heroin Tick all that apply Methadone (prescribed) Methadone (non-prescribed) Cocaine Heroin & Cocaine (together) Crack Heroin & crack (together) Anything else? Specify.... Years Months Q.30 What methods have you used for taking these drugs in the last month? Main method Methods also used Injecting into a vein or mainlining Skin popping Muscle popping Smoking Snorting or sniffing Into which parts of the body do you inject? Other, please specify... Q.31 Have you changed your dealer or supply of these drugs within the last month? Q.32 In which areas have you bought drugs in the last month? PLEASE SPECIFY THE NAME OF THE DISTRICT AND THE TOWN OR CITY FOR ALL PURCHASES IN THE LAST MONTH Q.33 Have you noticed anything different about your drugs recently in terms of: Colour Consistency Effect Dissolving If yes to any of these please give details: District or Area Town or City......

SECTION 3: QUESTIONS FOR DRUG USERS (continued) Q.34 Do you wash your hands before injecting? Q.35 Do you wipe the injection site with iodine, alcohol or a mediswab before injecting? Q.36 Do you wet your skin with saliva before or after injecting? Q.37 Do you lick the needle before injecting? Q.38 During the last month have you used any of the following to dissolve your drugs? Citric Acid Vinegar Lemon Juice (Jif) Lemon Juice (fresh) Descaler crystals Vitamin C Other If other, please specify... Q.39 Q.40 During the last month did you share any of the following with anyone? During the last month have you reused your own needles/syringes? If yes: In the last month, what is the maximum number of times you have reused the same needle/syringe? In the last month, where have you stored your used needles/syringes before reusing them? Citric Acid Needles & syringes Filter Spoons Water Other If other, please specify If yes to sharing spoons, how often did you use a spoon already used by someone else (including your partner)? times times In a closed container Uncovered Other, please specify..... Q.41 In the last month how many times have you visited a needle exchange (including pharmacy exchange)? times 8

SECTION 3: QUESTIONS FOR DRUG USERS (continued) Q.42 In the last month, what kind of water have you used to inject? Tick all that apply Q.43 When you injected in the last month, what have you used to filter your heroin? Tick all that apply Q.44 When you injected in the last month, have you re-used the same filter? If yes, How often? Boiled Bottled Sterile Tap (KITCHEN) Tap (BATHROOM) Cigarette filter Filter tips Cotton bud Cotton wool Clothing fibres times Other Specify... Nothing Anything else Specify. Where have you stored your used filters before reusing them? Q.45 During the last month, have you had any area of skin with redness, swelling and tenderness in an area that you inject? Q.46 Compared to a 1 pence coin, how large did it get? In a closed container Uncovered Other, please specify..... Smaller Same size Larger Much larger Don t Know Q.47 Did you seek medical attention for this skin problem? Q.48 How many abscesses have you had during the past year? Q.49 Is there anything else you that you think contributed to or caused this illness?.... THANK YOU FOR COMPLETING THE QUESTIONNAIRE 9